Direct in vivo characterization of delta 5 desaturase activity in humans by deuterium labeling: effect of insulin

Metabolism: Clinical and Experimental
S el BoustaniA Crastes de Paulet

Abstract

The conversion of dihomogamma linolenic acid (DHLA) into arachidonic acid (AA) was compared in normal subjects and diabetic patients before and after treatment with insulin. The kinetics of the incorporation of deuterium-labeled DHLA and its conversion product, deuterium-labeled AA, was determined in plasma triglycerides, plasma phospholipids, and platelet lipids of subjects after ingestion of 2 g of the labeled precursor. Analysis was performed by gas liquid chromatography-mass spectrometry using multiple ion detection. In normal subjects, the deuterium-labeled DHLA concentration rose to 24 to 69 mg/L in plasma triglycerides four to nine hours after ingestion and to 20 to 34 mg/L in plasma phospholipids about four hours later. Deuterium-labeled AA appeared at 12 hours, rose to 2.4 to 3.8 mg/L between 48 and 72 hours in plasma phospholipids, but remained at the limit of detection in plasma triglycerides and was undetectable in platelet lipids. In diabetic patients both before and after insulin treatment, the deuterium-labeled DHLA concentration in plasma triglycerides and in plasma phospholipids followed the same pattern as in normal subjects. However, the deuterium-labeled arachidonic acid concentration was below 1 mg/L in pla...Continue Reading

References

Feb 1, 1979·Lipids·K J StoneG P McNicol
Apr 1, 1977·The Journal of Nutrition·A G HassamM A Crawford
Jul 1, 1977·The Journal of Clinical Investigation·T K BillsM J Silver
Jun 23, 1975·Biochimica Et Biophysica Acta·A DanonJ A Oates
Nov 13, 1975·Nature·J P RiversM A Craqford
May 31, 1980·Lancet·T A SandersM Vickers
Nov 22, 1980·Lancet·A HiraiJ Jajiki

❮ Previous
Next ❯

Citations

Jul 13, 2017·International Journal of Food Sciences and Nutrition·Emily A DavidsonJenifer I Fenton
Jan 28, 1993·The New England Journal of Medicine·M BorkmanL V Campbell
Aug 17, 2006·Nutritional Neuroscience·Sam J Bhathena
Sep 11, 2004·Lipids·Kebreab GhebremeskelMichael A Crawford
Mar 27, 2010·Journal of the American College of Nutrition·Barry Sears
Jul 1, 2014·Current Nutrition Reports·Rasika A MathiasFloyd H Chilton
Mar 11, 2003·European Journal of Clinical Nutrition·D QuilliotO Ziegler
Nov 9, 2004·The American Journal of Clinical Nutrition·Erik J GiltayPeter L Zock
Oct 19, 2010·Journal of Obesity·Barry Sears, Camillo Ricordi
Feb 6, 2003·Journal of the American College of Nutrition·Samuel N Cheuvront
Mar 14, 2013·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Edina BerberovicJosip Djelmis
Mar 29, 2018·PloS One·Lindsay M ReynoldsFloyd H Chilton
Jun 14, 2020·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·María Catalina HernándezManuel Ruz
Oct 6, 1999·Prostaglandins, Leukotrienes, and Essential Fatty Acids·C L LoizouC N Hales
Aug 6, 2002·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·K GhebremeskelM A Crawford
Sep 27, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Y Lin, N Salem
Jan 23, 2003·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Rodolfo R Brenner
Jan 23, 2003·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Reza Zolfaghari, A Catharine Ross
Dec 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A K Dutta-Roy
Feb 27, 2007·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T DecsiGy Soltész
Sep 6, 2008·Prostaglandins, Leukotrienes, and Essential Fatty Acids·G SartoreD Fedele
Sep 14, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·Emilio Herrera, Henar Ortega-Senovilla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.